Questions discussed in this category
If using rituximab, how often are you treating the patient? E.g., every 6 months or alternatively, do you use a serological test like B cell number, M...
Risk factors include: non-IgG subtype, abnormal serum light chain ratio, M-protein >=1.5 mg/dL.
Further work up could include imaging, bone marrow...
New data suggests monoclonal gammopathies can be associated with thrombotic events. Is your practice changing to include monoclonal gammopathy evaluat...
When would you consider a bone marrow biopsy?
Does it assist in prognosis in any way?
Infection is not part of the criteria for starting treatment both in UpToDate and in NCCN guidelines.
What if the patient is no longer responding to steroids?
If so, what is your approach to laboratory and clinical testing?
2699711419230081759714008153021391687493906
Papers discussed in this category
Blood, 2017 Jan 19
The New England journal of medicine, 2024 Dec 09
European journal of haematology, 2013 Aug 17
Blood Cancer J, 2022 Sep 14
Blood, 2018-01-11
Continuum (Minneapolis, Minn.), 2020 Oct
Neurology(R) neuroimmunology & neuroinflammation, 2021 Nov 10